Reid M. Huber
Exec VP & Chief Scientific Off, Incyte.
Companies
- Rapport Therapeutics, Inc.Board member Jun 6, 2024 to now1
- CARGO Therapeutics, Inc.Board member Nov 9, 2023 to now2
- Tango Therapeutics (United States)Board member Aug 12, 2021 to Jun 8, 20233
- BELLICUM PHARMACEUTICALS, INCBoard member Dec 17, 2014 to Jan 20, 20234
- IncyteExec VP & Chief Scientific Off May 5, 2014 to Jul 18, 20185
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Rapport Therapeutics, Inc. RAPP20,400 shares6$584.5K at $28.65Sep 12, 2025
- Tango Therapeutics (United States) TNGX5,000 shares7$118.7K at $23.74Jun 6, 2023
- BELLICUM PHARMACEUTICALS, INC146,951 shares8Jan 3, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 12, 2025Bought 20,400 shares at $24.48 of Rapport Therapeutics, Inc.6
- Jun 6, 2023Granted 5,000 shares of Tango Therapeutics (United States)7
- Jan 3, 2023Exercised options 80,968 shares of BELLICUM PHARMACEUTICALS, INC8
- Jan 3, 2023Exercised options 87,196 shares of BELLICUM PHARMACEUTICALS, INC9
- Sep 1, 2022Exercised options 46,489 shares of BELLICUM PHARMACEUTICALS, INC10
- Jan 4, 2022Exercised options 19,494 shares of BELLICUM PHARMACEUTICALS, INC11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jan 5, 2023
- 10SEC EDGARForm 4 filed Sep 2, 2022
- 11SEC EDGARForm 4 filed Jan 6, 2022